SCHEMBL28622914

SCHEMBL28622914

O=C(NCCc1ccc2ccccc2c1)OC(=O)N1CCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.52
▸ HRH3 Q9Y5N1 1/20 0.47
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ GAA P10253 2/20 0.43
▸ MAPT P10636 4/20 0.43
▸ HTT P42858 4/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.40
▸ FAAH O00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28625455 0.81 KDM4E (0.49) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL28630343 0.80 GLA (0.58) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL28640398 0.80 ALDH1A1 (0.49) NPC1RAB9AHPGDALDH1A1GAA
SCHEMBL28631610 0.80 NPC1 (0.48) NPC1RAB9AHPGDALDH1A1GAA
SCHEMBL28923423 0.80 CNR1 (0.51) NPC1RAB9AHPGDALDH1A1GAA
SCHEMBL7439966 0.78 CES2 (0.52) CES2ALDH1A1GAAMAPTHTT
SCHEMBL3240006 0.77 CES2 (0.66) CES2NPC1RAB9AALDH1A1GAA
SCHEMBL28625023 0.77 CYP3A4 (0.47) HPGDALDH1A1GAAMAPTSMN1; SMN2
SCHEMBL28642116 0.75 TRPV1 (0.45) NPC1RAB9AHPGDALDH1A1MEN1
SCHEMBL15264439 0.74 CES2 (0.53) CES2ALDH1A1GAAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641878-B DIPROVOCIM: effective TLR agonist 斯克里普斯研究学院 2021-09-14 — — CN disclosed
Send feedback